A recent investigation demonstrated that a TZD-like molecule lacking PPAR-agonist activity attenuated weight gain and the development of NASH in mice placed on a high fat and cholesterol diet for 16 weeks. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatohepatitis.